Biogen Medical Research

Multiple Sclerosis

Scientific Objectives

We are currently only accepting proposals from the United States. 
The following areas of research are currently being considered:

  • Multiple Sclerosis (MS) and its treatment in special populations, i.e. geriatric or pediatric patients, family planning, LGBTQ+ patients, underrepresented populations
  • Diroximel Fumarate: Comparative effectiveness as assessed by PROs, quality of life, workability, treatment satisfaction and/or adherence vs newer DMTs in the treatment of naïve and/or switch patients
  • Natalizumab: Examination of long-term outcomes

Research support is awarded on a highly competitive basis, and submission of research proposals in these areas of interest does not guarantee support will be awarded. 

We continuously strive to improve our submission process and provide necessary guidance to investigators.